Drug with Neuroprotective Properties Noopept Does Not Stimulate Cell Proliferation
- Authors: Zainullina L.F.1, Ivanova T.V.2, Ostrovskaya R.U.1, Gudasheva T.A.1, Vakhitova Y.V.1, Seredenin S.B.1
- 
							Affiliations: 
							- V. V. Zakusov Research Institute of Pharmacology
- Institute of Biochemistry and Genetics, Ufa Federal Research Center of Russian Academy of Sciences
 
- Issue: Vol 166, No 4 (2019)
- Pages: 466-468
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/241108
- DOI: https://doi.org/10.1007/s10517-019-04373-8
- ID: 241108
Cite item
Abstract
Effects of Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) on the relative level of proliferation marker Ki-67 and cell cycle parameters were studied in HEK293 and SH-SY5Y cell lines. The previously established multifactorial mechanism of action of the drug includes enhancement of neurotrophin NGF and BDNF expression and increase in HIF-1 activity. The possible mitogenic action of Noopept was estimated by its effect on cell proliferation. Noopept did not affect cell distribution over G1, S, G2 cell cycle phases and the relative level of proliferation marker Ki-67 in the cell lines under study. These data suggest that Noopept does not stimulate cell growth.
About the authors
L. F. Zainullina
V. V. Zakusov Research Institute of Pharmacology
														Email: juvv73@gmail.com
				                					                																			                												                	Russian Federation, 							Moscow						
T. V. Ivanova
Institute of Biochemistry and Genetics, Ufa Federal Research Center of Russian Academy of Sciences
														Email: juvv73@gmail.com
				                					                																			                												                	Russian Federation, 							Ufa, Republic of Bashkortostan						
R. U. Ostrovskaya
V. V. Zakusov Research Institute of Pharmacology
														Email: juvv73@gmail.com
				                					                																			                												                	Russian Federation, 							Moscow						
T. A. Gudasheva
V. V. Zakusov Research Institute of Pharmacology
														Email: juvv73@gmail.com
				                					                																			                												                	Russian Federation, 							Moscow						
Yu. V. Vakhitova
V. V. Zakusov Research Institute of Pharmacology
							Author for correspondence.
							Email: juvv73@gmail.com
				                					                																			                												                	Russian Federation, 							Moscow						
S. B. Seredenin
V. V. Zakusov Research Institute of Pharmacology
														Email: juvv73@gmail.com
				                					                																			                												                	Russian Federation, 							Moscow						
Supplementary files
 
				
			 
					 
						 
						 
						 
						 
				 
  
  
  
  
  Email this article
			Email this article  Open Access
		                                Open Access Access granted
						Access granted Subscription Access
		                                		                                        Subscription Access
		                                					